University professors develop blood glucose breathalyzer
SPRINGFIELD, Mass. – Western New England University professors Dr. Ronny Priefer and Dr. Michael Rust have developed a hand-held breathalyzer that allows individuals to check their blood glucose levels. Instead of using finger-stick testing, patients blow into a breathalyzer to detect acetone levels in their breath. “We believe it is a necessary alternative to the finger-stick approach for people living with Type 1 and Type 2 diabetes,” said Priefer in a statement. “Necessary because as many as 66% of people with diabetes currently avoid doing the finger-stick testing due to the invasive and painful nature that patients must endure between 4-12 times a day.” Priefer hopes to have the device ready for sale by the end of next year.
Ascensia receives clearance for app-enabled blood glucose monitoring system
PARSIPPANY, N.Y. – Ascensia Diabetes Care has received clearance from the U.S. Food and Drug Administration for the Contour Next One blood glucose monitoring system. “This is an innovative new option for people living with diabetes,” said Robert Schumm, head of Ascencia Diabetes Care U.S., in a statement. “The system combines the remarkable accuracy of the Contour Next One meter with the easy-to-use features of the Contour Diabetes app and is designed to provide insights that may help people manage their diabetes in a better way.” The system features a smartLIGHT that provides instant feedback on blood glucose results, reminders and alerts to help support better management of diabetes, and an electronic logbook to record meals, activities and medication. Users can set up an optional secure cloud-based account to manage and store their data, and have the ability to email PDF summary reports to their provider. The Contour Next One system will be available in the U.S. early next year.
Cerner, American Well to deliver virtual health care experience
KANSAS CITY, Mo. – Cerner, a supplier of electronic health record systems, will work with American Well, a supplier of telemedicine technology solutions, to manage the virtual health and care of patients. “Together, we’re committed to developing a long-term strategy to align American Well’s technologies, services and programs to deliver an enhanced user experience within the Cerner EHR and ecosystem,” said Don Bisbee, Cerner’s senior vice president, in a statement. The integrated EHR-telehealth solution will allow clients of both companies to interact with Cerner’s HealtheLife patient portal.
Reliq Health to begin pilot with UK’s National Health Service
VANCOUVER, B.C. – Reliq Health Technologies will soon begin a virtual care technology pilot with a London-area hospital through the U.K.’s National Health Service. “Our technology is strongly aligned with the NHS England’s ongoing initiative to improve the management of long-term conditions in the community,” said Dr. Lisa Crossley, CEO of Reliq Health, in a statement. “Our platform uses a high-tech, low-touch approach to provide high quality health care in the home.” The pilot will focus on congestive heart failure and diabetes, using Reliq Health’s proprietary hardware and software supports to provide remote vitals monitoring, audible reminders, tailored patient education and secure communication with the care team.
Olea rolls out fall alert sensor
RENO, Nev. – Olea Sensor Networks has developed a platform with software analytics to predict a patient’s fall, or call for help if one occurs. BalancedSense includes a wireless, contact-less device that is able to collect and process data to predict deviations in a patient’s core balance and can send a call for assistance in the event of a fall. The system extracts statistics using Olea’s sensor analytics and transmits them through the cloud. “In general, call alert systems require the victim to be able to push a button, which is not always possible when disoriented or unconscious,” said Frank Morese, CEO/CTO and founder of Olea.
iCare Home Health expands website to serve disabled and visually impaired
OAKVILLE, Ontario – iCare Home Health has added a text-to-speech capability to its website to better serve its print disabled and visually impaired clients. “The audio technology is a natural fit on a website in the health care space and will best serve our growing client base and, specifically, the visually challenge demographic,” said Rick Menassa, iCare Home Health president, in a statement. A bright green “Listen” button has been added to all pages of the website. Visitors can click on the button to hear an entire page, or highlight a portion of the page to reveal a speaker.
Propeller Health teams with MIR for spirometers
MADISON, Wis. – Propeller Health has partnered with Medical International Research to offer several of MIR’s mobile and clinical spirometers within its Propeller platform. “Periodic assessment can be helpful in monitoring whether treatment is truly controlling symptoms and improving quality of life,” said David Van Sickle, Propeller CEO, in a statement. “These next-generation, mobile spirometers make it possible for patients to better understand their lung function at home and in the community.” Health care organizations using the Propeller digitally-guided respiratory therapy platform can incorporate the MIR spirometers into their existing programs, and data from the devices will be transmitted to the system’s platform.
Solera Health partners with Yes Health for mobile diabetes prevention
PHOENIX – Solera Health, an integrator of chronic disease prevention and management solutions, and Yes Health, an all-mobile program to prevent Type 2 diabetes, have teamed up to empower qualified, at-risk patients with access to Yes Health’s Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program (DPP), as a covered medical benefit. Yes Health will join Solera’s integrated network of partners. “We are thrilled to partner with Solera and give millions of at-risk patients access to real-time information and resources that can help them develop healthy habits that last a lifetime and prevent diabetes,” said Alex Petrov, founder and CEO of Yes Health, in a statement. Qualified patients will now have greater access to Yes Health’s platform that includes: one-on-one coaching, real-time nutrition and meal feedback, exercise motivation, stress reduction tips, and instant progress tracking.
Zebra Medical Vision launches web-based medical image analysis service
ISRAEL – Zebra Medical Vision has launched a web-based service that allows patients to receive fast, accurate medical image analysis.
The service, Profound, allows people to upload their medical imaging scans to Zebra’s online service and receive an automated analysis for key clinical conditions.
“Undergoing an imaging scan such as a CT or a mammogram is stressful for many people, often compounded by a long wait for results,” said Elad Benjamin, co-founder and CEO of Zebra. “Profound can help alleviate some of the anxiety involved by providing a second opinion for certain scans, or discovering key findings which were overlooked in others.”
Users can receive analysis highlighting the presence of conditions including osteoporosis, compression fractures, fatty liver, coronary calcium, emphysema and aortic aneurysms. Additional algorithms will be added soon.
“Our analysis does not replace a physician or a proper medical evaluation,” said Benjamin. “But with Profound, we hope to empower users to better manage and understand their health, promoting a better discourse with their physicians, which will lead to better care for everyone.”
Profound has launched in Europe, Asia, the Pacific Rim and Latin America.
Study shows Smartinhaler improves outcomes in children with asthma
MELBOURNE, Australia – There is a significant reduction in hospital admissions for children with asthma who used the Smartinhaler, according to a study by digital health technologies company Adherium Limited.
“This study provides good evidence that adherence monitoring with feedback can significantly improve clinical outcomes when used in the management of children with poorly controlled asthma,” said Dr. Robert Morton, lead investigator. “We would recommend this approach to be integrated into the standard care of children with poorly controlled asthma.”
The yearlong study at Sheffield Children’s Hospital included 77 children. Just over half of them used Smartinhaler adherence monitoring with medication reminders and feedback, and the rest received usual care. Drug use data were collected and children’s health outcomes were assessed at each three-month follow-up.
Adherence to prescribed medication averaged 70% in the intervention group, compared to 49% in the other group. The study found using the Smartinhaler increased medication adherence and that it was maintained over the course of 12 months. Nearly half of the children in the intervention group maintained average adherence rates of more than 80% over 12 months.
“The impact of adherence monitoring on the health of patients is clear and we continue to work with our partners to make it accessible to all those who would benefit,” said Garth Sutherland, CEO of Adherium.
Accredited Home Care, QOLPOM team to advance telehealth
SANTA MONICA, Calif. – Accredited Home Care has chosen QOLPOM to provide remote patient monitoring technologies to more than 15,000 patients in its Southern California service area.
“Increasing our operational efficiencies and the quality of life of our patients is the aim of our partnership with QOLPOM and its leading-edge technologies, monitoring system and an eye to the future,” said Barry Berger, founder and CEO of Accredited Home Care, in a statement.
QOLPOM, the telehealth subsidiary of Parallax Health Sciences, will provide its technology, medication dispensing and compliance services, logistics, hardware and secure network platform management to the program.
“Our scalable services and access to our exclusive QOLPOM HUB technologies throughout the coveted Southern California service area of Accredited Home Care is an exciting and notable 2016 achievement for our entire team,” said Nathanial Bradley, QOLPOM president, in a statement. “Our partnership with Accredited is a guiding light into the future and one that will showcase the very best nursing services working in combination with our groundbreaking technologies.”
ResApp gets green light for SMARTCOUGH-C study
BRISBANE – ResApp Health Limited has received institutional review board approval for the SMARTCOUGH-C study at Baylor College of Medicine, Texas Children’s Hospital, Cleveland Clinic and Massachusetts General Hospital.
“Our ultimate goal is to demonstrate the clinical accuracy of ResAppDx and improve the health care for children everywhere,” sasid Tony Keating, managing director and CEO of ResApp, in a statement.
SMARTCOUGH-C is a prospective, multi-site, double-blind study that will evaluate the efficacy of the ResAppDx software application in the diagnosis of childhood pneumonia and other respiratory conditions from cough sounds.
The primary endpoints for the study will be the diagnosis of pneumonia, with secondary endpoints being diagnosis of other common childhood respiratory diseases, such as upper respiratory tract infection, croup, bronchiolitis and asthma.
The details of the study will be published in the U.S. National Institutes of Health clinical trials database.